Nuclera Nucleics

Nuclera Nucleics

Verified
Making biology accessible by providing researchers a desktop bioprinter capable to produce genes and proteins in one day

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$62—93m (Dealroom.co estimates Jul 2022.)
Cambridge England (HQ)
  • Edit
DateInvestorsAmountRound
N/A£100kGrant
N/A£25kGrant
N/A£203kGrant
N/A$10mLate VC
*
$42.5mSeries B
*
$15.5mSeries B
Total Funding$68.4m

Recent News about Nuclera Nucleics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.